SCHEMBL18734940

SCHEMBL18734940

CCOC(=O)C(=O)CC(=O)SC(C)(C)C(NC(=O)C(C)C)C(=O)N(CC)CC

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.31
▸ METAP1 P53582 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734938 0.91 METAP2 (0.30) METAP2METAP1
SCHEMBL18734932 0.91 — —
SCHEMBL18734943 0.88 — —
SCHEMBL18735190 0.88 MGAM (0.33) METAP2METAP1
SCHEMBL18735323 0.87 METAP2 (0.36) METAP2METAP1
SCHEMBL18735144 0.83 — —
SCHEMBL18734928 0.81 — —
SCHEMBL18735160 0.81 LMNA (0.31) —
SCHEMBL18735315 0.81 METAP2 (0.36) METAP2METAP1
SCHEMBL18734944 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback